Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions - Morabito, A; Piccirillo, M C; Falasconi, F (Oncologist, 2009)
et al.